A scalp mesotherapy preparation resulting from 15 years of research and improvement at Caregen biotechnology laboratories, which are the world’s largest producer of biomimetic peptides and growth factors used in medical materials and cosmetics. It consists in injecting into the scalp 1 ml of a solution (in the syringe) inhibiting most of the processes leading to hair loss.

The biomimetic peptides are substances that bind to the receptors of living cells (e.g. skin, hair follicles) and influence the activity of these cells by mimicking the action of substances found in healthy, young skin (growth factors). The unique formulation – a complex of 7 peptides suspended in cross-linked hyaluronic acid – allows the release of the active substances in the scalp for 2 weeks after treatment.

Unique formulation:

  • Decapeptide-10, Octapeptide-11, Octapeptide-2 – stimulate growth and inhibit hair loss, stimulate the formation of new blood vessels in the scalp
  • Decapeptide-18; Decapeptide-28 – stimulate stem cells and keratinocytes. Strongly stimulate hair growth
  • Oligopeptide-54 – inhibits androgenetic alopecia by preventing the action of dihydrotestosterone on hair follicles
  • Oligopeptide-71 – stimulates new hair formation and pigment synthesis


The entire treatment consists of 4 treatments usually performed every 2-3 weeks. In many types of alopecia, if treatment is undertaken quickly, improvement can be achieved after just 1-2 treatments. In androgenetic alopecia, improvement is slower.